| Property | Value |
|---|
|
?:abstract
|
-
There has been impressive progress in malaria control and treatment over the past two decades. One of the most important factors in the decline of malaria-related mortality has been the development and deployment of highly effective treatment in the form of artemisinin-based combination therapies (ACTs). However, recent reports suggest that these gains stand the risk of being reversed due to the emergence of ACT resistance in the Greater Mekong Subregion and the threat of this resistance spreading to Africa, where the majority of the world’s malaria cases occur, with catastrophic consequences. This chapter provides an overview of strategies proposed by malaria experts to tackle artemisinin-resistant malaria, and some of the most important practical ethical issues presented by each of these interventions. The proposed strategies include mass antimalarial drug administrations in selected populations, and mandatory screening of possibly infected individuals prior to entering an area free of artemisinin-resistant malaria. We discuss ethical issues such as tensions between the wishes of individuals versus the broader goal of malaria elimination, and the risks of harm to interventional populations, and conclude by proposing a set of recommendations.
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:doi
|
-
10.1007/978-3-030-27874-8_4
|
|
?:doi
|
|
|
?:externalLink
|
|
|
?:journal
|
-
Ethics_and_Drug_Resistance:_Collective_Responsibility_for_Global_Public_Health
|
|
?:license
|
|
|
?:pdf_json_files
|
-
document_parses/pdf_json/5edc71581120239b6e04b5d72686b766db587a68.json
|
|
?:pmc_json_files
|
-
document_parses/pmc_json/PMC7586435.xml.json
|
|
?:pmcid
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
?:sha_id
|
|
|
?:source
|
|
|
?:title
|
-
Ethics and Antimalarial Drug Resistance
|
|
?:type
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}